Khan Sajjad A, Faraone Stephen V
SUNY Upstate Medical University, 750 East Adams Street, Syracuse, NY 13210, USA.
Curr Psychiatry Rep. 2006 Oct;8(5):393-7. doi: 10.1007/s11920-006-0042-y.
Investigations into the genetic basis of attention-deficit/hyperactivity disorder (ADHD) continue to yield compelling results as candidate gene studies reveal more information about this elusive disorder. Family, twin, and adoption studies further the notion that ADHD is a highly heritable disorder with direct genetic and environmental influence. The year 2005 saw many ADHD candidate gene studies, with most focused on the catecholaminergic candidates. Although many genes were studied in 2005, a large portion of findings has been supportive of the roles of dopaminergic genes' relationship to clinical phenotypes and drug response. These studies often require replication. Clinical implications continue to be speculative, as larger sample sizes are needed to validate findings to the general population. Further understanding of endophenotypes and the impact of comorbidities also is necessary for proper clinical intervention. Forthwith, we provide a summary of ADHD genetic studies published in 2005.
随着候选基因研究揭示出更多关于这种难以捉摸的疾病的信息,对注意力缺陷多动障碍(ADHD)遗传基础的研究不断产生令人信服的结果。家族、双胞胎和收养研究进一步支持了ADHD是一种具有高度遗传性的疾病,受到直接遗传和环境影响的观点。2005年出现了许多ADHD候选基因研究,其中大部分集中在儿茶酚胺能候选基因上。尽管2005年研究了许多基因,但大部分研究结果都支持多巴胺能基因与临床表型及药物反应之间的关系。这些研究通常需要重复验证。由于需要更大的样本量来向普通人群验证研究结果,临床意义仍具有推测性。对内在表型的进一步理解以及共病的影响对于适当的临床干预也很有必要。随即,我们对2005年发表的ADHD基因研究进行了总结。